Literature DB >> 9353492

The use of statins: a case of misleading priorities?

N Freemantle, R Barbour, R Johnson, M Marchment, A Kennedy.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9353492      PMCID： PMC2127566          DOI： 10.1136/bmj.315.7112.826

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

1.  Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation.

Authors:  D Kernick
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

2.  Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.

Authors:  L D Ritchie
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

3.  The primary prevention of coronary heart disease with statins: practice headache or public health?

Authors:  P H Evans
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

4.  Medicalisation, limits to medicine, or never enough money to go around?

Authors:  Nick Freemantle; Suzanne Hill
Journal:  BMJ       Date:  2002-04-13

Review 5.  The impact of health economics on healthcare delivery: the health economists' perspective.

Authors:  R McDonald; A Haycox; T Walley
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

6.  Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate.

Authors:  N Freemantle; J Mason
Journal:  BMJ       Date:  1999-05-29

7.  What do we gain from the sixth coronary heart disease drug?

Authors:  Rebecca N Warburton
Journal:  BMJ       Date:  2003-11-29

8.  From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia.

Authors:  K Fairhurst; G Huby
Journal:  BMJ       Date:  1998-10-24

9.  A simple computer program for guiding management of cardiovascular risk factors and prescribing.

Authors:  A D Hingorani; P Vallance
Journal:  BMJ       Date:  1999-01-09

Review 10.  Clinical guidelines-the hidden costs.

Authors:  A Haycox; A Bagust; T Walley
Journal:  BMJ       Date:  1999-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.